Skip to main content

GSA CAPITAL PARTNERS LLP

Position in CUE — Cue Biopharma, Inc.

CIK 1362033 LONDON, X0

Position in CUE

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$4,678
-$102,147 QoQ
Shares Held
20,341
-82.7% QoQ
Ownership
0.503%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 53 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CUE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $99,952,720 across 160 Biotechnology names. CUE ranks #160 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CUE

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,678 20,341
2025-03-31 $106,825 117,262
2024-12-31 $163,279 149,798
2024-09-30 $220,788 291,663
2024-06-30 $344,173 277,559
2024-03-31 $395,199 209,100
2023-12-31 $36,833 13,952
2023-06-30 $66,681 18,269
2023-03-31 $261,006 73,111
2022-12-31 $536,677 188,308
2022-09-30 $482,237 216,250
2022-06-30 $322,868 129,666
2022-03-31 $471,227 96,563
2021-12-31 $1,128,918 99,816
2021-09-30 $1,773,562 121,727
2021-06-30 $330,813 28,396
2021-03-31 $154,525 12,666
2020-12-31 $804,355 64,297
2020-09-30 $674,255 44,801